LipoCure Overview
LipoCure is developing a number of therapeutics utilizing proprietary liposome-based nano drugs with novel drug-loading capabilities and drug-release mechanisms. LipoCure's proprietary platform implements an approach that allows for remote drug loading into nano-liposomes and concomitant controlled release of the drugs at the targeted site. This technology is designed to produce an enhanced permeability and retention effect, a significantly improved therapeutic effect, and reduced side effects. It can be used in conjunction with several well-established drugs used for the treatment of rheumatoid arthritis, multiple sclerosis, and cancer. LipoCure's founder is professor Yechezkel Barenholz, the co-developer of Doxil.
Cumulative Funding Raised Over Time ($)
Latest News
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $8M |
| Last funding | $8M |
| Stage | A |
| Rounds | 1 |
| Investors | 2 |
Team Members
3
Employees: 1-10
Web & Social Links
| Website | lipocurerx.com/ |
Locations
Hadassah Ein Kerem Campus, Jerusalem, Israel
Photos & Videos
1 item(s)
LipoCure Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryTarget Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsCore Technology
Materials & SubstancesNanomaterialsTags (9)
oncologynanotechnologyinflammatory-diseasespharmaceuticalsmedical-technologiessustained-releaseimmunotherapydrug-deliverypharma-companiesGeographic Markets
United StatesLipoCure Financials
Cumulative Funding Raised Over Time ($)
Private Equity Funding
LipoCure Lifecycle
Cumulative Funding Raised Over Time
All Events
LipoCure News
1 articleLipoCure Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 8 |
| Team members | 3 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 8 classification IDs that could be used for matching.
LipoCure Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 86/100 |
| Missing | not claimed |
| BI Verification | Sharon Shapira |
| Registrar ID | 513757005 |
| Crunchbase | lipocure |
| Phone | +97225722040 |
| Last updater | Paul Weisko |
| Updater email | pweisko@gmail.com |
| Last update | 2021-04-26T00:00:00.000Z |
| Created | 2014-09-23T00:00:00.000Z |